225 related articles for article (PubMed ID: 54050)
1. Diagnosis of systemic lupus erythematosus. Importance of antinuclear antibody titers and peripheral staining patterns.
Nisengard RJ; Jablonska S; Chorzelski TP; Blaszcyk M; Jarret C; Beutner EH
Arch Dermatol; 1975 Oct; 111(10):1298-300. PubMed ID: 54050
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
Parker MD; Turner RA
Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
[TBL] [Abstract][Full Text] [Related]
3. [Possibilities of differentiation of antinuclear antibodies].
Müller W; Rosenthal M; Stojan B
Z Gesamte Inn Med; 1975 Oct; 30(20):665-71. PubMed ID: 766433
[TBL] [Abstract][Full Text] [Related]
4. Antinucleolar antibodies. Their frequency and diagnostic association.
Ritchie RF
N Engl J Med; 1970 May; 282(21):1174-8. PubMed ID: 4909324
[No Abstract] [Full Text] [Related]
5. Disease distributions in patients with multiple patterns of nuclear staining detected by FANA (immunofluorescent antinuclear antibody) tests.
Rothberger H; Lee TK; Wise C
Clin Exp Rheumatol; 1986; 4(3):201-7. PubMed ID: 3533338
[TBL] [Abstract][Full Text] [Related]
6. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
Burnham TK; Neblett TR; Fine G; Bank P
Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
[No Abstract] [Full Text] [Related]
7. Evaluation of fluorescent antinuclear antibody assays, Crithidia luciliae substrate, and single-stranded DNA-binding capacity in diagnosis of four rheumatic diseases.
Chiang M; Chia D; Barnett EV
J Clin Microbiol; 1982 Apr; 15(4):684-7. PubMed ID: 7040465
[TBL] [Abstract][Full Text] [Related]
8. Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases.
Wei Q; Jiang Y; Xie J; Lv Q; Xie Y; Tu L; Xiao M; Wu Z; Gu J
J Clin Lab Anal; 2020 Dec; 34(12):e23546. PubMed ID: 33047841
[TBL] [Abstract][Full Text] [Related]
9. Antinuclear antibodies (ANA): immunologic and clinical significance.
Fernandez-Madrid F; Mattioli M
Semin Arthritis Rheum; 1976 Nov; 6(2):83-124. PubMed ID: 62398
[TBL] [Abstract][Full Text] [Related]
10. Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus.
Sjöwall C; Sturm M; Dahle C; Bengtsson AA; Jönsen A; Sturfelt G; Skogh T
J Rheumatol; 2008 Oct; 35(10):1994-2000. PubMed ID: 18785312
[TBL] [Abstract][Full Text] [Related]
11. Diseases in which antinuclear antibody and-or rheumatoid factor are usually present. (Rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis).
Sheon RP; Kirsner AB
Med Times; 1973 Feb; 101(2):97-113. PubMed ID: 4539866
[No Abstract] [Full Text] [Related]
12. Comparative evaluation of antinuclear factor tests in rheumatic disorders.
Willkens RF; Decker JL; Wilske KR
Med Clin North Am; 1968 May; 52(3):559-65. PubMed ID: 4385202
[No Abstract] [Full Text] [Related]
13. Comparison of mouse liver sections and cultured mouse fibroblasts as substrates for the detection of antinuclear antibodies.
Lubiniecki AS
Am J Clin Pathol; 1976 Nov; 66(5):892-8. PubMed ID: 790937
[TBL] [Abstract][Full Text] [Related]
14. Substrate specificity of antinuclear antibodies in scleroderma.
Blaszczyk M; Beutner EH; Rogozinski T; Rzesa G; Jarzabek-Chorzelska M; Jablonska S; Chorzelski TP
J Invest Dermatol; 1977 Apr; 68(4):191-3. PubMed ID: 66298
[TBL] [Abstract][Full Text] [Related]
15. Proceedings: A simple immunofluorescence method for differentiation of ANF between RA and healthy persons and SLE and scleroderma patients.
Stojan B
Ann Rheum Dis; 1975 Apr; 34(2):197-8. PubMed ID: 1094966
[No Abstract] [Full Text] [Related]
16. Antinuclear antibodies in pleural fluid.
Khare V; Baethge B; Lang S; Wolf RE; Campbell GD
Chest; 1994 Sep; 106(3):866-71. PubMed ID: 8082370
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus.
Permin H; Wiik A
Acta Pathol Microbiol Scand C; 1978 Oct; 86C(5):245-9. PubMed ID: 309705
[TBL] [Abstract][Full Text] [Related]
18. [Clinical usefulness of detection of serum antinuclear antibodies by the immunofluorescence method].
Wranicz A
Przegl Dermatol; 1971; 58(6):685-90. PubMed ID: 4945137
[No Abstract] [Full Text] [Related]
19. [Diagnostic approaches in systemic lupus erythematosus (author's transl)].
Häcki MA; Grob PJ
Dtsch Med Wochenschr; 1976 Jan; 101(1):13-6. PubMed ID: 1106979
[TBL] [Abstract][Full Text] [Related]
20. Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.
Parker MD; Kerby GP
Ann Rheum Dis; 1974 Sep; 33(5):465-72. PubMed ID: 4608364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
